-
1
-
-
41149097574
-
Adoptive cell transfer: A clinical path to effective cancer immunotherapy
-
Rosenberg SA et al (2008) Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 8(4):299-308
-
(2008)
Nat Rev Cancer
, vol.8
, Issue.4
, pp. 299-308
-
-
Rosenberg, S.A.1
-
3
-
-
0033556322
-
High avidity CTLs for two self antigens demonstrate superior in vitro and in vivo antitumor efficacy
-
Zeh HJI et al (1999) High avidity CTLs for two self antigens demonstrate superior in vitro and in vivo antitumor efficacy. J Immunol 162:989-994
-
(1999)
J Immunol
, vol.162
, pp. 989-994
-
-
Zeh, H.J.I.1
-
4
-
-
0030760194
-
Tumor antigens recognized by T lymphocytes
-
Van den Eynde BJ, Boon T (1997) Tumor antigens recognized by T lymphocytes. Int J Clin Lab Res 27(2):81-86
-
(1997)
Int J Clin Lab Res
, vol.27
, Issue.2
, pp. 81-86
-
-
Van Den Eynde, B.J.1
Boon, T.2
-
5
-
-
0034507693
-
Impact of negative selection on the T cell repertoire reactive to a self-peptide: A large fraction of T cell clones escapes clonal deletion
-
DOI 10.1016/S1074-7613(00)00080-7
-
Bouneaud C, Kourilsky P, Bousso P (2000) Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity 13:829-840 (Pubitemid 32041805)
-
(2000)
Immunity
, vol.13
, Issue.6
, pp. 829-840
-
-
Bouneaud, C.1
Kourilsky, P.2
Bousso, P.3
-
6
-
-
0032909172
-
Immunotherapy with CTLs restricted by nonself MHC
-
Stauss HJ (1999) Immunotherapy with CTLs restricted by nonself MHC. Immunol Today 20:180-183
-
(1999)
Immunol Today
, vol.20
, pp. 180-183
-
-
Stauss, H.J.1
-
7
-
-
4444219513
-
Exploiting alloreactivity for tumour immunotherapy
-
Stauss HJ et al (2004) Exploiting alloreactivity for tumour immunotherapy. Vox Sang 87(Suppl 2):227-229
-
(2004)
Vox Sang
, vol.87
, Issue.SUPPL. 2
, pp. 227-229
-
-
Stauss, H.J.1
-
8
-
-
58149384550
-
Graft-versus-leukemia effects of transplantation and donor lymphocytes
-
Kolb HJ (2008) Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood 112(12):4371-4383
-
(2008)
Blood
, vol.112
, Issue.12
, pp. 4371-4383
-
-
Kolb, H.J.1
-
9
-
-
0034648702
-
Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stemcell transplantation
-
Childs R et al (2000) Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stemcell transplantation. N Engl J Med 343(11):750-758
-
(2000)
N Engl J Med
, vol.343
, Issue.11
, pp. 750-758
-
-
Childs, R.1
-
10
-
-
0036852191
-
Natural selection of tumor variants in the generation of "tumor escape" phenotypes
-
Khong HT, Restifo NP (2002) Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat Immunol 3(11):999-1005
-
(2002)
Nat Immunol
, vol.3
, Issue.11
, pp. 999-1005
-
-
Khong, H.T.1
Restifo, N.P.2
-
11
-
-
33751536158
-
Immune selective pressure and HLA class i antigen defects in malignant lesions
-
Chang CC, Ferrone S (2007) Immune selective pressure and HLA class I antigen defects in malignant lesions. Cancer Immunol Immunother 56:227-236
-
(2007)
Cancer Immunol Immunother
, vol.56
, pp. 227-236
-
-
Chang, C.C.1
Ferrone, S.2
-
12
-
-
0037639186
-
MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components
-
DOI 10.1002/ijc.11241
-
Garcia-Lora A et al (2003) MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components. Int J Cancer 106(4):521-527 (Pubitemid 36966208)
-
(2003)
International Journal of Cancer
, vol.106
, Issue.4
, pp. 521-527
-
-
Garcia-Lora, A.1
Martinez, M.2
Algarra, I.3
Gaforio, J.J.4
Garrido, F.5
-
13
-
-
68049118980
-
Loss of mismatched HLA in leukemia after stem-cell transplantation
-
Vago L et al (2009) Loss of mismatched HLA in leukemia after stem-cell transplantation. N Engl J Med 361(5):478-488
-
(2009)
N Engl J Med
, vol.361
, Issue.5
, pp. 478-488
-
-
Vago, L.1
-
14
-
-
33645749031
-
Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants
-
van Hall T et al (2006) Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat Med 12(4):417-424
-
(2006)
Nat Med
, vol.12
, Issue.4
, pp. 417-424
-
-
Van Hall, T.1
-
15
-
-
34248172485
-
TCRβ chain that forms peptide-independent alloreactive TCR transfers reduced reactivity with irrelevant peptide/MHC complex
-
Santori FR et al (2007) TCRβ chain that forms peptide-independent alloreactive TCR transfers reduced reactivity with irrelevant peptide/MHC complex. J Immunol 178:6109-6114
-
(2007)
J Immunol
, vol.178
, pp. 6109-6114
-
-
Santori, F.R.1
-
16
-
-
58149180575
-
Adaptable TCR avidity thresholds for negative selection
-
Stojakovic M etal (2008) Adaptable TCR avidity thresholds for negative selection. J Immunol 181:6770-6778
-
(2008)
J Immunol
, vol.181
, pp. 6770-6778
-
-
Stojakovic, M.1
-
18
-
-
37849188785
-
Sampling of major histocompatibility complex class I-Associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides
-
DOI 10.1016/j.humimm.2006.08.294, PII S0198885906004824
-
Gebreselassie D, Spiegel H, Vukmanovic S (2006) Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides. Hum. Immunol 67:894-906 (Pubitemid 44828201)
-
(2006)
Human Immunology
, vol.67
, Issue.11
, pp. 894-906
-
-
Gebreselassie, D.1
Spiegel, H.2
Vukmanovic, S.3
-
19
-
-
0030917013
-
The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with beta-2 microglobulin and peptide
-
USA
-
Balendiran GK et al (1997) The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with beta-2 microglobulin and peptide. Proc Natl Acad Sci USA 94(13):6880-6885
-
(1997)
Proc Natl Acad Sci
, vol.94
, Issue.13
, pp. 6880-6885
-
-
Balendiran, G.K.1
-
20
-
-
0027362645
-
+ T-cell clone
-
USA
-
+ T-cell clone Proc Natl Acad Sci USA 90:11272-11276
-
(1993)
Proc Natl Acad Sci
, vol.90
, pp. 11272-11276
-
-
Udaka, K.1
-
21
-
-
0028046593
-
Identification of a unique antigen peptide pRL1 on BALB/c RL♂1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene
-
DOI 10.1084/jem.180.5.1599
-
Uenaka A et al (1994) Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene. J Exp Med 180:1599-1607 (Pubitemid 24328552)
-
(1994)
Journal of Experimental Medicine
, vol.180
, Issue.5
, pp. 1599-1607
-
-
Uenaka, A.1
Ono, T.2
Akisawa, T.3
Wada, H.4
Yasuda, T.5
Nakayama, E.6
-
22
-
-
28444491760
-
Identification of mouse AAV capsidspecific CD8 +T cell epitopes
-
Sabatino DE et al (2005) Identification of mouse AAV capsidspecific CD8 +T cell epitopes. Mol Ther 12(6): 1023-1033
-
(2005)
Mol Ther
, vol.12
, Issue.6
, pp. 1023-1033
-
-
Sabatino, D.E.1
-
23
-
-
0028466130
-
Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
-
Kearney ER et al (1994) Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1(4):327-339
-
(1994)
Immunity
, vol.1
, Issue.4
, pp. 327-339
-
-
Kearney, E.R.1
-
24
-
-
22244437207
-
Lessons to be learned from primary renal cell carcinomas: Novel tumor antigens and HLA ligands for immunotherapy
-
DOI 10.1007/s00262-004-0650-5
-
Kruger T et al (2005) Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy. Cancer Immunol Immunother 54:826-836 (Pubitemid 40991325)
-
(2005)
Cancer Immunology, Immunotherapy
, vol.54
, Issue.9
, pp. 826-836
-
-
Kruger, T.1
Schoor, O.2
Lemmel, C.3
Kraemer, B.4
Reichle, C.5
Dengjel, J.6
Weinschenk, T.7
Muller, M.8
Hennenlotter, J.9
Stenzl, A.10
Rammensee, H.-G.11
Stevanovic, S.12
-
25
-
-
0344026273
-
+ T cell specificity and compensates for loss of T cell receptor contacts with the specific peptide
-
+ T cell specificity and compensates for loss of T cell receptor contacts with the specific peptide. J Exp Med 189:883-893
-
(1999)
J Exp Med
, vol.189
, pp. 883-893
-
-
Sandberg, J.K.1
Karre, K.2
Glas, R.3
|